Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Challenges in investigation of diabetes-related aviation fatalities-an analysis of 1491 subsequent aviation fatalities in USA during 2011-2016.

Junttila IS, Vuorio A, Budowle B, Laukkala T, Sajantila A.

Int J Legal Med. 2018 Nov;132(6):1713-1718. doi: 10.1007/s00414-018-1879-4. Epub 2018 Jul 4.

PMID:
29974235
2.

Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes.

Junttila IS.

Front Immunol. 2018 Jun 7;9:888. doi: 10.3389/fimmu.2018.00888. eCollection 2018. Review.

3.

Mental health assessment in rehabilitation: a descriptive study through an international internet survey.

Juengst S, Nordvik JE, Junttila IS, Smith J, Kew CL, Laukkala T.

Int J Rehabil Res. 2018 Dec;41(4):368-372. doi: 10.1097/MRR.0000000000000300.

PMID:
29912785
4.

Subjective and objective measures of function and return to work: an observational study with a clinical psychiatric cohort.

Laukkala T, Heikinheimo S, Vuokko A, Junttila IS, Tuisku K.

Soc Psychiatry Psychiatr Epidemiol. 2018 May;53(5):537-540. doi: 10.1007/s00127-017-1479-5. Epub 2017 Dec 23.

PMID:
29275503
5.

R-Ras deficiency does not affect papain-induced IgE production in mice.

Kummola L, Ortutay Z, Vähätupa M, Prince S, Uusitalo-Järvinen H, Järvinen TAH, Junttila IS.

Immun Inflamm Dis. 2017 Sep;5(3):280-288. doi: 10.1002/iid3.168. Epub 2017 May 11.

6.

IL-7Rα Expression Regulates Murine Dendritic Cell Sensitivity to Thymic Stromal Lymphopoietin.

Kummola L, Ortutay Z, Chen X, Caucheteux S, Hämäläinen S, Aittomäki S, Yagi R, Zhu J, Pesu M, Paul WE, Junttila IS.

J Immunol. 2017 May 15;198(10):3909-3918. doi: 10.4049/jimmunol.1600753. Epub 2017 Apr 12.

7.

Efficient cytokine-induced IL-13 production by mast cells requires both IL-33 and IL-3.

Junttila IS, Watson C, Kummola L, Chen X, Hu-Li J, Guo L, Yagi R, Paul WE.

J Allergy Clin Immunol. 2013 Sep;132(3):704-712.e10. doi: 10.1016/j.jaci.2013.03.033. Epub 2013 May 14.

8.

Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines.

Junttila IS, Creusot RJ, Moraga I, Bates DL, Wong MT, Alonso MN, Suhoski MM, Lupardus P, Meier-Schellersheim M, Engleman EG, Utz PJ, Fathman CG, Paul WE, Garcia KC.

Nat Chem Biol. 2012 Dec;8(12):990-8. doi: 10.1038/nchembio.1096. Epub 2012 Oct 28.

9.

Cytokine-induced cytokine production by conventional and innate lymphoid cells.

Guo L, Junttila IS, Paul WE.

Trends Immunol. 2012 Dec;33(12):598-606. doi: 10.1016/j.it.2012.07.006. Epub 2012 Sep 5. Review.

10.

The transcription factor GATA3 actively represses RUNX3 protein-regulated production of interferon-gamma.

Yagi R, Junttila IS, Wei G, Urban JF Jr, Zhao K, Paul WE, Zhu J.

Immunity. 2010 Apr 23;32(4):507-17. doi: 10.1016/j.immuni.2010.04.004. Epub 2010 Apr 15.

11.

Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages.

Heller NM, Qi X, Junttila IS, Shirey KA, Vogel SN, Paul WE, Keegan AD.

Sci Signal. 2008 Dec 23;1(51):ra17. doi: 10.1126/scisignal.1164795.

12.

Tuning sensitivity to IL-4 and IL-13: differential expression of IL-4Ralpha, IL-13Ralpha1, and gammac regulates relative cytokine sensitivity.

Junttila IS, Mizukami K, Dickensheets H, Meier-Schellersheim M, Yamane H, Donnelly RP, Paul WE.

J Exp Med. 2008 Oct 27;205(11):2595-608. doi: 10.1084/jem.20080452. Epub 2008 Oct 13.

Supplemental Content

Loading ...
Support Center